Equity Medical, Llc

New York, New York 10023

3 studies enrolling now · 8 studies all time

What they study most

Atopic Dermatitis, Chronic Inducible Urticaria, Chronic Obstructive Pulmonary Disease, Chronic Spontaneous Urticaria, Cold Urticaria, Cold-Induced Urticaria, Hidradenitis Suppurativa, NonSegmental Vitiligo, Prurigo Nodularis, Refractory or Unexplained Chronic Cough, Symptomatic Dermographism

Studies at this site

• Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa — Recruiting now
• A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD) — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
• A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) — Recruiting now
• Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough — Running, not enrolling
• A Study of Barzolvolimab in Patients With Atopic Dermatitis — Running, not enrolling
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream — Completed